ZLTQ 27.49 Zeltiq Aesthetics Inc $ZLTQ Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ZLTQ 27.49 Zeltiq Aesthetics Inc $ZLTQ Hit a 52 week high of 27.99 Currently at 27.49 -0.25 -0.90% With a day low of 26.53 and a total volume of 668,400.

ZLTQ Zeltiq Aesthetics Inc Recent Headline News

Technical Coverage on Health Care Equipment Stocks - Boston Scientific, Zeltiq Aesthetics, Globus Medical, Volcano, and Stryker
PR Newswire - Thu Nov 06, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), Globus Medical Inc. (NYSE: GMED), Volcano Corporation (NASDAQ: VOLC), and Stryker Corporation (NYSE: SYK). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Wednesday, November 5, 2014, the NASDAQ Composite ended at 4,620.72, down 0.06%, the Dow Jones Industrial Average advanced 0.58%, to finish the day at 17,484.53, and the S&P 500 closed at 2,023.57, up 0.57%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.22, down 0.19%, while the index has advanced 10.98% in the previous three months. Register for your complimentary reports on these five stocks at:
BSX: 13.24 (-0.12), ZLTQ: 27.49 (-0.25), GMED: 21.48 (-0.58), VOLC: 9.99 (+0.07), SYK: 87.47 (-1.08)

Consumer Names Show Big Growth And New Patterns
at Investor's Business Daily - Wed Nov 05, 4:42PM CST
Stocks from the consumer sector are making their presence felt in today's Spotlight. Some of these companies show outstanding current earnings growth, but digging a little deeper reveals some flaws as well. Zeltiq Aesthetics (ZLTQ) rose briefly after...
JACK: 71.83 (-1.17), ZLTQ: 27.49 (-0.25), RJET: 12.60 (-0.22), CMG: 649.03 (+1.91), FRGI: 55.59 (+0.11)

Zeltiq Aesthetics (ZLTQ) Upgraded From Sell to Hold
at The Street - Mon Nov 03, 9:04AM CST
Zeltiq Aesthetics (ZLTQ) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ZLTQ: 27.49 (-0.25)

Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders
at The Street - Fri Oct 31, 9:15AM CDT
Stocks with insider trader activity include TYL, SWHC and ZLTQ
ZLTQ: 27.49 (-0.25), TYL: 110.25 (-0.30), SWHC: 9.99 (-0.07)

Owens & Minor Earnings Lag on High Costs, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:04PM CDT
Owens & Minor Inc. (OMI), reported mixed third-quarter 2014 results.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), OMI: 33.95 (-0.27)

Watch Electronic Arts, SolarWinds, 2 More for Upside Momentum
at The Street - Thu Oct 30, 12:05PM CDT
Big recent moves in these four stocks suggest the likelihood of continued momentum.
SWI: 48.31 (+0.03), ZLTQ: 27.49 (-0.25), EA: 40.94 (+0.14), AMED: 24.79 (-0.38)

5 Stocks Spiking on Unusual Volume
at The Street - Thu Oct 30, 6:00AM CDT
Keep these stocks rising on unusual volume on your trading radar.
ZLTQ: 27.49 (-0.25), GPRE: 35.03 (+0.77), WMB: 55.38 (+0.67), OMG: 26.70 (+0.06), IPGP: 72.83 (-0.74)

Medtronic Initiates Clinical Study on Latest Heart Valve - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 5:10PM CDT
Medtronic's (MDT) structural heart business expanded in the upper teens owing to exceptional performance delivered by its transcatheter valves.
ZLTQ: 27.49 (-0.25), MDT: 68.10 (-0.64), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21)

Stock Futures Mixed, Improving; Facebook, Orbital Sciences Dive
at Investor's Business Daily - Wed Oct 29, 8:02AM CDT
Stock futures shifted from losses to mixed trade on the approach to Wednesday's open. Dow futures improved from a narrow decline to trade 16.3 points above fair market value. S&P 500 futures narrowed their losses to a fraction. Nasdaq 100 futures...
ZLTQ: 27.49 (-0.25), ORB: 24.24 (+0.01), FB: 75.60 (+0.34)

Zeltiq beats Street 3Q forecasts
Automated Insights - Tue Oct 28, 6:52PM CDT
PLEASANTON, Calif. (AP) _ Zeltiq Aesthetics Inc. (ZLTQ) on Tuesday reported third-quarter net income of $4.8 million.
ZLTQ: 27.49 (-0.25)

ZELTIQ AESTHETICS
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
ZELTIQ AESTHETICS (ZLTQ), maker of the CoolSculpting fat-freezing tech, earned 12 cents a share vs. a year-earlier 8-cent loss and views for another 8-cent loss. Revenue surged 55% to $46 mil, topping. Zeltiq raised its full-year revenue and adjusted...
ZLTQ: 27.49 (-0.25)

Zeltiq Aesthetics Earnings: Shaping Up for Another Beat
Rick Munarriz, The Motley Fool - Motley Fool - Tue Oct 28, 4:38PM CDT
Source: Zetliq Aesthetics.  Freezing away stubborn fat cells continues to pay off for Zeltiq Aesthetics . The company behind the CoolSculpting platform that's gaining traction in reshaping love handles, abdomens, and thighs posted another...
ZLTQ: 27.49 (-0.25)

ZELTIQ Announces Third Quarter 2014 Financial Results
Marketwired - Tue Oct 28, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
ZLTQ: 27.49 (-0.25)

Baxter International Gets FDA Nod for Hemophilia A Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 5:45PM CDT
Baxter International Inc.'s (BAX) OBIZUR, cleared for the treatment of bleeding episodes in adults with acquired hemophilia A (AHA), will be commercially available in the U.S. in the coming months.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), BAX: 70.61 (-0.99)

3 Things to Watch When Zeltiq Aesthetics Reports Earnings
Rick Munarriz, The Motley Fool - Motley Fool - Mon Oct 27, 12:24PM CDT
Source: Zetliq Aesthetics.  Slimming down remains a challenge for a lot of people, and that's been an opportunity for Zeltiq Aesthetics . The company behind the CoolSculpting platform has been growing quickly as cosmetic surgeons, dietitians,...
ZLTQ: 27.49 (-0.25)

ResMed Posts In-Line Earnings on Revenue Beat in Q1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:50AM CDT
Following the earnings release, ResMed's (RMD) share price rose 9.1% to close at $52.02 on Friday.
ZLTQ: 27.49 (-0.25), GWPH: 73.97 (-0.41), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)

Strength Seen in ResMed (RMD): Stock Gains 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:46AM CDT
ResMed (RMD) was a big mover last session, with shares rising just over 9% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), RMD: 51.14 (-0.43)

Can Fat-Freezer Zeltiq Aesthetics Heat Up Profits?
at Investor's Business Daily - Fri Oct 24, 4:50PM CDT
After some flabby years, things are shaping up for fat-busting technology developer Zeltiq Aesthetics. Zeltiq (ZLTQ) offers people a way to get rid of unwanted fat with its nonsurgical CoolSculpting procedure, which selectively reduces bulges in...
ISRG: 500.02 (-8.63), ELOS: 9.90 (+0.11), VRX: 126.11 (-2.66), ZLTQ: 27.49 (-0.25), VAR: 84.64 (-0.53), CFN: 57.28 (-0.16), STNR: 42.38 (+0.51)

Strength Seen in Cardica (CRDC): Stock Adds 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:25AM CDT
Cardica (CRDC) was a big mover last session, with shares rising over 6% on the day.
ICUI: 71.16 (-0.89), ZLTQ: 27.49 (-0.25), ABAX: 51.63 (-2.21), CRDC: 0.96 (+0.01)

Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 27.49 (-0.25), PAHC: 28.34 (+1.48), GWPH: 73.97 (-0.41), TRIB: 17.43 (-0.42)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innventure Faces Legal Scrutiny Over DarkNX Debacle

Updated Category News Views 70

Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...

Continue Reading
Minesto Teams Up to Unlock Tidal Power in Maldives

Updated Category News Views 154

The world of ocean energy just got a jolt from an unlikely corner. Minesto, the ocean energy whiz, and Morteza Capital, a savvy investment force entrenched in the Maldives, are shaking hands to usher tidal energy into this paradise. Tidal Waves Meet Tourism When you're talking about the Maldives, you're talking about two main things: pristine tropical getaways and a whole...

Continue Reading
Bank of America Faces Legal Battle Over Compliance Failures

Updated Category News Views 39

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Continue Reading
Veterans, Lawmakers Forge Paths in Spokane Forum

Updated Category News Views 0

Spokane Forum Sparks Action for Veterans' Policies Gonzaga University turned into a powerhouse of dialogue and determination as the Wounded Warrior Project (WWP) gathered over 145 veterans, elected officials, and advocate groups to hash out critical policy priorities. We're talking high-stakes discussions with real consequences, not just some feel-good meet-up. A...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 347

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
Medline's Decade-Long WRAP Partnership: More Than Labels

Updated Category News Views 144

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

Continue Reading
Reimagining Water: A Crisis and a Call to Action

Updated Category News Views 121

Time for a Change The head of the World Water Council, Loïc Fauchon, didn't mince words at the 9th Cairo Water Week. He proclaimed the old methods of water management are sinking under a flood of modern challenges. Toss in climate upheavals, ballooning cities, and unpredictable diets, and you've got yourself a swirling mess that traditional strategies just can’t mop...

Continue Reading
UFP Industries Fortifies Gulf Coast with $27M Buy

Updated Category News Views 65

UFP Industries Makes a Strategic Move Folks, it looks like UFP Industries (NASDAQ: UFPI) is making some solid moves down in the Gulf Coast, and they're shelling out $27 million to do it. This time, they've got their eyes on Apache Products, dba Acme Skid, a company that's been doing the heavy lifting in the pallet manufacturing space in Silsbee, Texas. Apparently, these...

Continue Reading
CSQR Faces Scrutiny Over Cash Flow Discrepancies

Updated Category News Views 40

Dalrymple's Short Report Shakes Csquare's Core Csquare, Inc. (NYSE: CSQR) is reeling from a one-two punch: a damning short report by Dalrymple Finance and an 11.8% share tumble. The timing of this financial body blow, coinciding with Csquare's discordant cash flow claims, could mark the beginning of a long battle for investor trust. This ain't the first time the markets...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 121

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading

Top 5 Most Recently Viewed Articles

Johnson & Johnson Stock Analysis: Performance and Predictions

Updated Category News Views 189

Current Performance of Johnson & Johnson Stock Johnson & Johnson (NYSE: JNJ) has made a significant impression this year, with the stock soaring nearly 42.9% to date. This impressive growth includes a rise of about 35% over the past six months and an 8.6% uptick in just the past month. Investors are keen to know what’s driving this positive trend. Recent Earnings Report...

Continue Reading
Thombar Empowers Specialty Crop Growers with New Banking Solutions

Updated Category News Views 141

Thombar Launches to Support Specialty Crop Growers A new banking platform is designed specifically for the unique needs of U.S. specialty crop growers. Introducing Thombar, a pioneering financial technology company that has just launched a new banking platform aimed at empowering specialty crop growers across the nation. Specializing in the diverse agricultural landscape,...

Continue Reading
Investigation of Snap Inc. Securities Fraud: What Investors Need to Know

Updated Category News Views 239

Understanding the Current Legal Situation for Snap Inc. The Gross Law Firm has issued an important notice that could impact numerous shareholders of Snap Inc. (NYSE: SNAP). As part of an ongoing class action lawsuit, those who purchased SNAP shares during the specified class period are encouraged to seek guidance on potential legal recourse. Who Should Consider...

Continue Reading
Alfa|SIGMA Achieves Impressive 1Q25 EBITDA Growth

Updated Category News Views 328

Alfa|SIGMA Reports Strong Results for 1Q25 Alfa, S.A.B. de C.V. has unveiled its financial accomplishments for the first quarter of 2025, showcasing a significant EBITDA of $220 million. This remarkable performance indicates the company's steady trajectory toward achieving its ambitious target of $1 billion for the full year. Highlights of 1Q25 Performance Transformative...

Continue Reading
Discover the A-688 Rotary Stage: Unmatched Precision in Motion

Updated Category News Views 149

Unveiling the A-688 Rotary Stage for Precise Motion Control The A-688 rotary stage, crafted by PI, represents an evolution in precision motion control solutions. This innovative product is designed to offer maintenance-free performance along with ultra-high resolution and high-speed capabilities. Frictionless Design for Superior Performance Engineered with a unique...

Continue Reading